Savara Inc. (SVRA)
NASDAQ: SVRA
· Real-Time Price · USD
3.72
0.14 (3.91%)
At close: Sep 05, 2025, 3:59 PM
3.64
-2.15%
After-hours: Sep 05, 2025, 05:09 PM EDT
3.91% (1D)
| Bid | 3.36 |
| Market Cap | 642.95M |
| Revenue (ttm) | 272K |
| Net Income (ttm) | -110.33M |
| EPS (ttm) | -0.51 |
| PE Ratio (ttm) | -7.29 |
| Forward PE | -6.98 |
| Analyst | Buy |
| Ask | 3.88 |
| Volume | 2,472,088 |
| Avg. Volume (20D) | 1,301,880 |
| Open | 3.61 |
| Previous Close | 3.58 |
| Day's Range | 3.58 - 3.83 |
| 52-Week Range | 1.89 - 4.70 |
| Beta | 0.40 |
About SVRA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SVRA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SVRA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
+9.79%
Savara shares are trading higher. Guggenheim maint...
Unlock content with
Pro Subscription
3 months ago
-31.69%
Savara shares are trading lower after the company announced it received a refusal to file letter from the FDA for its biologics license application.
2 months ago · accessnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Savara Inc. - SVRANEW YORK CITY, NY / ACCESS Newswire / June 16, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Savara Inc.("Savara" or the "Company") (NASDAQ:SVRA). Such investors are advised t...